INTRODUCTION {#sec1-1}
============

High-risk behaviors are normal part of maturity. These risky activities are associated with predictable, although often unforeseen, consequences.\[[@ref1]\] Young inmates, compared with their peers, begin high risk sexual activity earlier; have more partners, initiation of injection drug use, and higher rates of sexually transmitted diseases.\[[@ref2]\] Health studies of juvenile inmates indicate rates of risk behaviors affecting physical health.\[[@ref3]\] Factors such as low socioeconomic status, high risky sexual behaviors, injection drug use may be evolved in them before incarceration. After entrance to prison, it may be connected to additional risk factors such as sexual harassment, non-professional tattooing, psychological stress, poor ventilation systems, and crowded living conditions.\[[@ref4]\]

Hepatitis B virus (HBV) and human immunodeficiency virus (HIV) are blood borne pathogens, which are efficiently transmitted by percutaneous or per mucosal exposure to infectious blood or body fluids.\[[@ref5]\] The prevalence of HBV infection worldwide is 5%, which makes it a global health problem.\[[@ref6]\] It is estimated that 50 million new cases are being detected annually with 5-10% of adults and up to 90% of infants becoming chronically infected.\[[@ref7]\] Among prisoners, the prevalence of serological markers HBV infection is 13-47%, and varies among different regions.\[[@ref5]\]

Young inmates are at heightened risk for HIV infection due to higher prevalence of psychopathology and substance use disorders, compared with their no offending peers. Young ones with psychiatric disorders are at greater risk because of unprotected sexual behaviors than their peers who are not coping with mental health issues.\[[@ref2]\] Therefore, young offenders are particularly at risk for HBV and HIV.

We undertook a survey to determine the seroprevalence of HBV and HIV in young prisoners.

MATERIALS AND METHODS {#sec1-2}
=====================

During 2008-2009, the cross-sectional study was conducted among prisoners in Isfahan, Iran. All the 160 prisoners, who were younger than 19 years of age, after signed a written informed consent form was enrolled voluntarily by census method. Researchers recorded a check-list for each participant through a face-to-face interview. Any question could be skipped by inmates. The checklist included socio-demographic data, drug and sexual history, and duration of incarceration.

Having a history of at least one time injection was considered as intravenous drug use. This study was approved by the Ethical Committee of Isfahan University of Medical Sciences, Isfahan, Iran.

Five milliliter blood sample was obtained from each participant. Serum samples were stored at --20°C until analyzing. HBV antibody was assayed with commercial enzyme-linked immunosorbent assays (ELISA) for hepatitis B surface antigen (HBs Ag) kit (Diapro, Italy), total hepatitis B core antibody (HBc Ab) kit (Diapro, Italy) and hepatitis B surface antibody (HBs Ab) kit (Diapro, Italy). Testing for antibody to HIV was performed with commercial ELISA (Diapro, Italy) confirmed by Western blot (INNO-LIA HIV I/II Score), which assessed p24, p31, gp41, p120, gp 36, p105, and p17 antigens.

Samples were tested for HBs Ag to estimate recent infection. A specimen was considered HIV seropositive if it was reactive to both ELISA and Western blot. The data was analyzed with descriptive statistical methods by Statistical Package for the Social Sciences software, version 15.

RESULTS {#sec1-3}
=======

The age range of subjects was from 12 to 19 years old with the mean age of 16.59 ± 1.24. Most of the subjects were boy (91.9%) and had a low-level of education (77.5%) \[[Table 1](#T1){ref-type="table"}\]. Sixty from 160 inmates self-reported a history of illegal sex. The finding showed that 29.4% of cases had a history of drug abuse. Of the 160 participants, 44 had the history of being incarcerated before the present time.

###### 

Demographic characteristics of subjects
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[Table 2](#T2){ref-type="table"} shows the results of serological test. The seroprevalence of HBs Ag, HBc Ab, and HIV was 0.6%. HBs Ag and HBc Ab were detected in one 17-year-old boy with 2 times incarcerations and more than 1 year of duration of being in prison.

###### 

Serological tests
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A 15-year-old boy was HIV positive, one number of incarceration and less than 60 days of being in prison. Among 160 juveniles, 52 (32.5%) individuals were positive for HBs Ab.

According to the small number of HBs Ag, HBc Ab, and HIV (one case), no test of association with risk factors could be performed.

DISCUSSION {#sec1-4}
==========

In this study we evaluated the seroprevalence of HBs Ag, HBc Ab, HBs Ab, and HIV among juveniles in a prison in Isfahan. Such studies have been undertaken in some of countries but reports on these infections among young prisoners are scarce in our country.n comparison with other studies, we found low seropositivity of HBs Ag and HBc Ab. Butler *et al*.\[[@ref3]\] reported 11% of young offenders tested positive for HBc Ab. The prevalence of HBc Ab was 4% among young prisoner in England and Wales.\[[@ref8]\] HBc Ab and HBs Ag were reported 11% and 4% among juvenile detainees in Australia.\[[@ref9]\] A study which was done in Melborne juvenile justice center\[[@ref1]\] reported 8% had been exposed to HBV. In a study in Taiwan, the prevalence of HBs Ag was 24.5% in participants aged 10-20 years.\[[@ref10]\] Adoga reported HBs Ag seroprevalence rate of 10% in the age group 15-20 year in a prison in Nigeria.\[[@ref11]\]

More than 65% of these juveniles had no immunity against hepatitis B. In Iran mass vaccination of neonates against HBV infection started in 1993 as a national program.\[[@ref12]\] Therefore, this program has not covered some of these young people who were born before 1993. Although our finding shows the HBV prevalence is still low in this group but many studies\[[@ref13][@ref14][@ref15]\] showed that the prevalence of HBV infection is generally higher in prisoners than in non-prisoners. These researches indicate that prisons could be also high-risk places for infection transmission and they can have an important effect on rate of infection. Therefore, antibody testing for immunity against HBV and performing of hepatitis B vaccination programs in prison and correctional setting should be conducted in our country.

Our results indicated prevalence of HIV seropositivity is 0.6% in this population. In Butler *et al*. study\[[@ref3]\] none of young prisoners were positive for HIV. In comparison with other studies in Brazil,\[[@ref16]\] Maryland,\[[@ref17]\] and Argentina\[[@ref18]\] we found low seropositivity of HIV. However, it was similar to finding from UK,\[[@ref19]\] USA,\[[@ref20]\] and Australia.\[[@ref9]\] According to the absence of risk factors for this patient, HIV infection can be due to vertical transmission.

Unfortunately, we did not assessed the knowledge and understanding of risks related to transmission of these infections in this study. However, we know more than 75% of this population had less than high school education and it could be acceptable that the most of them did not know about transmission routes of these infections. Therefore, educating inmates about prominent potential route for transmission of these blood borne disease is very important.

Our study had several limitations. First, it included a low number of cases and only a positive case for HBV and HIV, and thus, it is difficult to make a clear statement about the risk factors. Second, data was collected by means self-report questionnaire through an interview.

According to the prevalence rate of HBS Ab and doing high-risk behaviors in this high-risk group, implementation program on immunization of this population should be considered. Since education programs are the most important and effective way of preventing such disease, such programs should be performed constantly for all prisoners.

CONCLUSION {#sec1-5}
==========

With respect to national vaccination program against HBV infection in Iran, the juvenile prisoners had low prevalence of HBs Ab.
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